BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...
Here are the latest biotech industry updates: introducing new platforms for SPR, RNA-seq libraries and DNA extraction.
Although there are striking differences between the cells that make up your eyes, kidneys, brain and toes, the DNA blueprint ...
News-Medical.Net on MSN
Study explores how reversible RNA editing could transform future cardiovascular medicine
By Hugo Francisco de Souza Emerging research suggests reversible RNA editing mechanisms may influence heart disease biology while opening new avenues for biomarkers and next-generation cardiovascular ...
A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...
News-Medical.Net on MSN
Tahoe Therapeutics generates the largest single-cell atlas ever using INTEGRA Biosciences automated pipetting technologies
Tahoe Therapeutics - a biotech start-up based in San Francisco, California - is creating the largest ever atlas of ...
ArgenTag have joined PacBio’s Compatible Partner Program and opened a grant to provide access to single-cell sequencing tech.
University of Queensland research has revealed that double-stranded RNA-based biopesticides (dsRNA) sprayed on plant leaves can travel right down into root systems. Led by Dr. Chris Brosnan at UQ's ...
ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell resolution.
Haoyu Cheng, Ph.D., assistant professor of biomedical informatics and data science at Yale School of Medicine, has developed a new algorithm capable of building complete human genomes using standard ...
Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results